Answers are grounded in this paper and cite their sources.
Cutaneous manifestations occur in the course of hematologic malignancies and precede, accompany or occur late in relation to the diagnosis. They result from paraneoplastic phenomena, tumor infiltrations, immunosuppression resulting from the hematologic disease itself or its treatment. The dermatologist must be aware of these conditions that may be helpful both in the diagnosis of the underlying disease and in reducing patient morbidity. This review (part II) addresses the paraneoplastic dermatological changes associated with systemic hematologic malignancies.
No takes yet. Share an insight, caveat, or question.
Souza et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: